Diversion Control
Diversion Control is a regulatory framework within controlled substance policy that constitutes the systematic monitoring, prevention, and interdiction of legally manufactured pharmaceuticals from entering illicit channels, distinguishing it from broader drug control strategies by its focus on the unauthorized transfer of substances within legitimate supply chains.
95
Publications
3.3K
Citations
283
Authors
142
Institutions
Publications per year
2017–2026
22
95
Theodore J. Cicero, James A. Inciardi, Edgar H. Adams et al. · Pharmacoepidemiology and Drug Safety · 2005 · 125 citations
Keith H. Berge, Kevin R. Dillon, Karen M. Sikkink et al. · Mayo Clinic Proceedings · 2012 · 125 citations · Full text
1–5 of 95
283
7
h-index
The Ohio State University Wexner Medical Center, United States
4 publications · 62 citations
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 283
142
The University of Kansas Health System
Kansas City, United States
6 h-index
7 publications
101 citations
The Ohio State University Wexner Medical Center
Columbus, United States
4 h-index
5 publications
90 citations
University of Kentucky
Lexington, United States
4 h-index
14 publications
354 citations

Johns Hopkins University
Baltimore, United States
4 h-index
10 publications
315 citations
The Ohio State University
Columbus, United States
4 h-index
5 publications
90 citations

University of New England
Biddeford, United States
3 h-index
6 publications
78 citations
University of Pittsburgh Medical Center
Pittsburgh, United States
3 h-index
10 publications
254 citations
University of Pittsburgh
Pittsburgh, United States
3 h-index
7 publications
114 citations
1–8 of 142
6 publications · 83 citations
6
h-index
4 publications · 86 citations
4
h-index
Repository · 4 publications · 78 citations
4
h-index
JDI · 4 publications · 103 citations
4
h-index
4 publications · 254 citations
4
h-index
1–5